306 related articles for article (PubMed ID: 32655575)
1. Congenital Hemolytic Anemias: Is There a Role for the Immune System?
Zaninoni A; Fermo E; Vercellati C; Marcello AP; Barcellini W; Bianchi P
Front Immunol; 2020; 11():1309. PubMed ID: 32655575
[TBL] [Abstract][Full Text] [Related]
2. Confounding factors in the diagnosis and clinical course of rare congenital hemolytic anemias.
Fattizzo B; Giannotta JA; Cecchi N; Barcellini W
Orphanet J Rare Dis; 2021 Oct; 16(1):415. PubMed ID: 34627331
[TBL] [Abstract][Full Text] [Related]
3. Iron overload in congenital haemolytic anaemias: role of hepcidin and cytokines and predictive value of ferritin and transferrin saturation.
Barcellini W; Zaninoni A; Gregorini AI; Soverini G; Duca L; Fattizzo B; Giannotta JA; Pedrotti P; Vercellati C; Marcello AP; Fermo E; Bianchi P; Cappellini MD
Br J Haematol; 2019 May; 185(3):523-531. PubMed ID: 30828802
[TBL] [Abstract][Full Text] [Related]
4. Clinical and hematologic benefits of partial splenectomy for congenital hemolytic anemias in children.
Rice HE; Oldham KT; Hillery CA; Skinner MA; O'Hara SM; Ware RE
Ann Surg; 2003 Feb; 237(2):281-8. PubMed ID: 12560788
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the main regulators of systemic iron homeostasis in pyruvate kinase deficiency.
Zaninoni A; Marra R; Fermo E; Consonni D; Andolfo I; Marcello AP; Rosato BE; Vercellati C; Barcellini W; Iolascon A; Bianchi P; Russo R
Sci Rep; 2023 Mar; 13(1):4395. PubMed ID: 36927785
[TBL] [Abstract][Full Text] [Related]
6. [Congenital hemolytic anemias due to erythrocyte membrane and enzyme defects].
Génevaux F; Bertsch A; Wiederer L; Eber S
Dtsch Med Wochenschr; 2022 Sep; 147(19):1266-1276. PubMed ID: 36126925
[TBL] [Abstract][Full Text] [Related]
7. Severe Presentation of Congenital Hemolytic Anemias in the Neonatal Age: Diagnostic and Therapeutic Issues.
Cortesi V; Manzoni F; Raffaeli G; Cavallaro G; Fattizzo B; Amelio GS; Gulden S; Amodeo I; Giannotta JA; Mosca F; Ghirardello S
Diagnostics (Basel); 2021 Aug; 11(9):. PubMed ID: 34573891
[TBL] [Abstract][Full Text] [Related]
8. Detection of red blood cell antibodies in mitogen-stimulated cultures from patients with hereditary spherocytosis.
Zaninoni A; Vercellati C; Imperiali FG; Marcello AP; Fattizzo B; Fermo E; Bianchi P; Grossi C; Cattaneo A; Cortelezzi A; Zanella A; Barcellini W
Transfusion; 2015 Dec; 55(12):2930-8. PubMed ID: 26259504
[TBL] [Abstract][Full Text] [Related]
9. Hepcidin and Anemia: A Tight Relationship.
Pagani A; Nai A; Silvestri L; Camaschella C
Front Physiol; 2019; 10():1294. PubMed ID: 31649559
[TBL] [Abstract][Full Text] [Related]
10. Recommendations regarding splenectomy in hereditary hemolytic anemias.
Iolascon A; Andolfo I; Barcellini W; Corcione F; Garçon L; De Franceschi L; Pignata C; Graziadei G; Pospisilova D; Rees DC; de Montalembert M; Rivella S; Gambale A; Russo R; Ribeiro L; Vives-Corrons J; Martinez PA; Kattamis A; Gulbis B; Cappellini MD; Roberts I; Tamary H;
Haematologica; 2017 Aug; 102(8):1304-1313. PubMed ID: 28550188
[TBL] [Abstract][Full Text] [Related]
11. Congenital Hemolytic Anemia.
Haley K
Med Clin North Am; 2017 Mar; 101(2):361-374. PubMed ID: 28189176
[TBL] [Abstract][Full Text] [Related]
12. [Molecular pathology of the erythrocyte membrane. Erythrocyte membrane defects as a cause of congenital hemolytic anemia].
Schröter W; Eber SW
Monatsschr Kinderheilkd; 1989 Jul; 137(7):368-79. PubMed ID: 2677683
[TBL] [Abstract][Full Text] [Related]
13. Multi-gene panel testing improves diagnosis and management of patients with hereditary anemias.
Russo R; Andolfo I; Manna F; Gambale A; Marra R; Rosato BE; Caforio P; Pinto V; Pignataro P; Radhakrishnan K; Unal S; Tomaiuolo G; Forni GL; Iolascon A
Am J Hematol; 2018 May; 93(5):672-682. PubMed ID: 29396846
[TBL] [Abstract][Full Text] [Related]
14. Use of Laser Assisted Optical Rotational Cell Analyzer (LoRRca MaxSis) in the Diagnosis of RBC Membrane Disorders, Enzyme Defects, and Congenital Dyserythropoietic Anemias: A Monocentric Study on 202 Patients.
Zaninoni A; Fermo E; Vercellati C; Consonni D; Marcello AP; Zanella A; Cortelezzi A; Barcellini W; Bianchi P
Front Physiol; 2018; 9():451. PubMed ID: 29755372
[TBL] [Abstract][Full Text] [Related]
15. CD44 as a Potential Screening Marker for Preliminary Differentiation Between Congenital Dyserythropoietic Anemia Type II and Hereditary Spherocytosis.
Singleton BK; Ahmed M; Green CA; Heimpel H; Woźniak MJ; Ranjha L; Seeney F; Bomford A; Mehta P; Guest A; Mushens R; King MJ
Cytometry B Clin Cytom; 2018 Mar; 94(2):312-326. PubMed ID: 27784127
[TBL] [Abstract][Full Text] [Related]
16. Rare Hereditary Hemolytic Anemias: Diagnostic Approach and Considerations in Management.
Risinger M; Emberesh M; Kalfa TA
Hematol Oncol Clin North Am; 2019 Jun; 33(3):373-392. PubMed ID: 31030808
[TBL] [Abstract][Full Text] [Related]
17. Congenital Dyserythropoietic Anemia Type II With Myelofibrosis in an Adult Patient: A Report of a Rare Case With a Brief Review.
Shemawat S; Bansal S; Mathur A; Mittal A; Sharma M
Cureus; 2024 Apr; 16(4):e58515. PubMed ID: 38765414
[TBL] [Abstract][Full Text] [Related]
18. Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II.
Casanovas G; Swinkels DW; Altamura S; Schwarz K; Laarakkers CM; Gross HJ; Wiesneth M; Heimpel H; Muckenthaler MU
J Mol Med (Berl); 2011 Aug; 89(8):811-6. PubMed ID: 21475976
[TBL] [Abstract][Full Text] [Related]
19. A case of successful management with splenectomy of intractable ascites due to congenital dyserythropoietic anemia type II-induced cirrhosis.
Vassiliadis T; Garipidou V; Perifanis V; Tziomalos K; Giouleme O; Patsiaoura K; Avramidis M; Nikolaidis N; Vakalopoulou S; Tsitouridis I; Antoniadis A; Semertzidis P; Kioumi A; Premetis E; Eugenidis N
World J Gastroenterol; 2006 Feb; 12(5):818-21. PubMed ID: 16521204
[TBL] [Abstract][Full Text] [Related]
20. [Reduced deformability of erythrocytes as a common denominator of hemolytic anemias].
Tillmann W
Wien Med Wochenschr; 1986; 136 Spec No():14-6. PubMed ID: 3548086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
